Moderna Update: MRNA
On July 31, we discussed Moderna, one of the two big C-19 vaccine manufacturers. We discussed two situations: earnings and the longer-term trend. This article is for paid members -…
Moderna: MRNA
If there is any company that reaks of SARS-COVID-19, it is Moderna. This company claims that C-19 is preventable with its mRNA gene-altering technology. The other company to use this…
Close Moderna Trade: MRNA
Back in February, we suggested investors take a bearish position in Moderna. This article is for registered members - please login or click here to subscribe or register for free.
Moderna (MRNA)
On Friday, 16-July-2021, the Options Action gang talked about Modena. The Chargemaster Carter Braxton Worth showed that the share price was butting up again a rising trend line. By his…
Moderna (MRNA)
Moderna, Inc. is a biotech company that develops therapeutics and vaccines based on messenger RNA technology to treat infectious diseases. They, of course, have been the biggest beneficiary of the…
MRNA: Moderna
Moderna is one of the many companies working on a vaccine for the SARS-Covid-2, aka Covid-19. We have talked about this company in the past, and while we held the…
Trade Updates: MRNA (Moderna)
Moderna is one of those companies the world hopes can deliver on their promises. But in the world of drug and vaccine development, nothing is certain except for massive regulation…
MRNA: Has Moderna Had its Day?
Moderna broke on the scene, claiming that one of its drugs in development may be an effective vaccine against COVID-19. Naturally, the manic market speculators took the share price and…